<article>Financial services firm <a style="color: #000080;" href="http://www.chinabridgecapital.com" target="_blank">China Bridge Capital</a> has invested up to $45 million (RMB300 million) in biotech startup <a style="color: #000080;" href="http://www.icarbonx.com/en/" target="_blank">iCarbonX</a>, creator of an artificial intelligence-enabled health data mining platform.</article>

Financial services firm <a style="color: #000080;" href="http://www.chinabridgecapital.com" target="_blank">China Bridge Capital</a> has invested up to $45 million (RMB300 million) in biotech startup <a style="color: #000080;" href="http://www.icarbonx.com/en/" target="_blank">iCarbonX</a>, creator of an artificial intelligence-enabled health data mining platform.
Touted as a strategic investment, China Bridge Capital also plans to establish a special purpose investment fund targeting RMB10 billion to acquire precision healthcare assets, an area iCarbonX is expanding into, the <a style="color: #000080;" href="http://www.chinamoneynetwork.com/" target="_blank">China Money Network</a> reported.
China Bridge Capital is a financial services firm closely linked to Chinese Internet firm <a style="color: #000080;" href="http://www.leeco.com" target="_blank">LeEco</a>.
Based in Shenzhen, Guangdong Province, iCarbonX was officially launched last October 2015 with the goal of building an ecosystem of digital life based on a combination of individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.
On its sixth month last April, iCarbonX closed a RMB1 billion series A round led by Tencent Holdings Ltd, gaining company valuation of RMB6.5 billion.
Prior to that round, last January, reports said Shanghai-listed cell and gene engineering firm <a style="color: #000080;" href="http://www.vcanbio.com/about.aspx" target="_blank">Vcanbio Cell &amp; Gene Engineering Corporation Ltd</a> was investing RMB100 million as part of iCarbonX&#8217;s funding round.
iCarbonX founder Wang Jun, the former chief executive of genome sequencing giant Beijing Genomic Institute (BGI), recently announced that their first commercial product would be in personalized cosmetics and skincare products.
&#8220;iCarbonx will create the first and also the most professional data collection platform of life-time data from millions of individuals in China, combine the best biotechnology and artificial intelligence team, and integrate the advantages of artificial intelligence into big data analyses and applications of human’s life data through data mining and machine learning,&#8221; the company said in a statement.
Also Read:
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/china-biotech-company-icarbonx-valued-at-1b-after-series-a-round-37210/" target="_blank">China: Biotech company iCarbonX valued at $1b after Series A round</a>
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/australiamelbourne-biotech-venture-cnsdose-secures-47323/" target="_blank">Melbourne biotech venture CNSDose secures $1m from two angel investors</a>
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/shenzhen-hepalink-invests-60m-tpg-biotechnologys-latest-fund-44864/" target="_blank">Shenzhen Hepalink invests $60m in TPG Biotechnology’s latest fund</a>
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/41150-41150/" target="_blank">LeEco acquires Beijing commercial development project for $455m</a>

 China Bridge Capital has invested up to $45 million in biotech startup iCarbonX, creator of an artificial intelligence-enabled health data mining platform

China Bridge Capital invests $45m in biotech startup iCarbonX

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

China Bridge Capital invests $45m in biotech startup iCarbonX

Start your deal-making journey now!

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief